Purdue Pharma, a company that has earned billions of dollars in selling a prescription for pain relieving OxyContin, said on Wednesday that it is considering filing a bankruptcy petition, as it is struggling to bring lawsuits to ensure that the firm is responsible for the national opioid crisis. stating that he is studying and preparing for any number of options and options, taking into account the number of trials that the company now faces, "said spokeswoman Perd & Robert Johnson.
Hundreds of local and state governments sued Perd and other drugs. producers and distributors who claim they are responsible for the national opioid crisis because they allegedly deceive and aggressively promote their products. separately.
KANSAS'S TREATMENT INTRODUCES LIFE IN THE OFFICE AFTER THE EXISTING PATIENT'S DAY D The President and Chief Executive Officer of Purdue, Craig Landau, told The Washington Post that the company had not finally taken a bankruptcy decision, but given the impact of legal fees or jury trials, Purdue Pharma can cost billions of dollars.
"We are considering it, but we really did not make decisions about which way to pursue. Much depends on what is unfolding in the coming weeks and months, "Landau said.
Since the release of OxyContin in 1
Although these drugs are only part of the prescribed opioids, documents from the Massachusetts Attorney General assume that, in order to spread drug sales, Purdue has mislead doctors. did not want to appoint a strong pain reliever to their patients. She stated that Pardy had neglected safety and dependence, and doctors were convinced that their drugs were safe to increase profits at the expense of patients who were addicted to their products.
Purdue is the main accused in a court on May 28 against the State of Oklahoma. The prosecutor's office can look for more than $ 1 billion from pharmaceutical companies, reports The Post.
Click here to get FOX news APP
The prosecutor's office consolidated most litigation lawsuits in the federal court in Cleveland, where negotiations are underway to resolve up to two scheduled tests this fall, but a bankruptcy hearing is likely , stop legal proceedings for Purdue.
Purdue Pharma is a privately owned company of seven Sackler, which hired an executive and consulting team with experience in restructuring companies during legal and financial crises. Massachusetts court records show that seven have received more than $ 4 billion from Purdue in the period from 2007 to 2018.
Associated press contributed to this report.